RYTM
Rhythm Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$102.80
−2.00%Leverage
- Debt / equity
- 0.02x
- Net debt / equity
- -0.29x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.02x
- Net debt / EBITDA
- 0.34x
Liquidity & coverage
- Current ratio
- 3.45x
- Quick ratio
- 3.20x
- Cash ratio
- 2.68x
- Interest coverage
- -10.86x
- EBITDA / interest
- -10.00x
- Working capital
- $303.0M
Cash & dividend
- FCF / debt
- -40.87x
- Cash flow / debt
- -40.61x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026